This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Original paper

Association between proton pump inhibitors and the risk of hepatocellular carcinoma

Volume: 48, Issue: 4, Pages: 460 - 468
Published: Jun 13, 2018
Abstract
Summary Background Proton pump inhibitor ( PPI ) use has been reported to be associated with liver damage and might possibly be carcinogenic. Aims We examined whether long‐term PPI use increases the risk of hepatocellular carcinoma ( HCC ) in patients without viral hepatitis B or C. Methods We conducted a nested case‐control study in a cohort of patients without viral hepatitis in Taiwan from 2000 to 2013. In total, 29 473 HCC cases and 294 508...
Paper Details
Title
Association between proton pump inhibitors and the risk of hepatocellular carcinoma
Published Date
Jun 13, 2018
Volume
48
Issue
4
Pages
460 - 468
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.